School of Biological Sciences, Seoul National University, South Korea.
Center for Systems Geroscience, Seoul National University, South Korea.
FEBS J. 2024 May;291(10):2091-2093. doi: 10.1111/febs.17141. Epub 2024 Apr 22.
Cellular immortalization is a complex process that requires multiple genetic alterations to overcome restricting barriers, including senescence. Not surprisingly, many of these alterations are associated with cancer; two tumor suppressor pathways, the cellular tumor antigen p53 and p16-Retinoblastoma (RB) pathways, are the best-characterized examples, but their mutations alone are known to be insufficient to drive full immortalization. En et al. identified a role for the lamin B receptor (LBR) in promoting cellular proliferation and immortalization in p53- and RB-deficient cells by maintaining their genome integrity and suppressing senescence. Thus, modulation of LBR could be exploited to treat cancer and potentially also to promote cell rejuvenation.
细胞永生化是一个复杂的过程,需要多个遗传改变来克服限制障碍,包括衰老。毫不奇怪,其中许多改变与癌症有关;两种肿瘤抑制途径,细胞肿瘤抗原 p53 和 p16-Retinoblastoma (RB) 途径,是最典型的例子,但已知它们的突变本身不足以完全实现永生化。En 等人发现,层粘连蛋白 B 受体 (LBR) 通过维持基因组完整性和抑制衰老,在 p53 和 RB 缺陷细胞中促进细胞增殖和永生化,从而发挥作用。因此,LBR 的调节可以被利用来治疗癌症,并可能促进细胞年轻化。